Evidence map›Paper›PMID 32958752›Full record

ArticleCell death & disease2020

Correction: Calcium sensing receptor protects high glucose-induced energy metabolism disorder via blocking gp78-ubiquitin proteasome pathway.

Yuehong Wang, Ping Gao, Can Wei, Hongzhu Li, Li Zhang, Yajun Zhao, Bo Wu, Ye Tian, Weihua Zhang, Lingyun Wu and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Yuehong WangDepartment of Pathophysiology, Harbin Medical University, Harbin, 150086, China.
Ping GaoDepartment of Endocrinology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.
Can WeiDepartment of Pathophysiology, Harbin Medical University, Harbin, 150086, China.
Hongzhu LiDepartment of Pathophysiology, Harbin Medical University, Harbin, 150086, China.
Li ZhangDepartment of Pathophysiology, Harbin Medical University, Harbin, 150086, China.
Yajun ZhaoDepartment of Pathophysiology, Harbin Medical University, Harbin, 150086, China.
Bo WuDepartment of Pathophysiology, Harbin Medical University, Harbin, 150086, China.
Ye TianDepartment of Pathophysiology, Harbin Medical University, Harbin, 150086, China.
Weihua ZhangDepartment of Pathophysiology, Harbin Medical University, Harbin, 150086, China.
Lingyun WuThe Cardiovascular and Metabolic Research Unit, Laurentian University, Sudbury, ON, Canada, P3E 2C6.
Rui WangThe Cardiovascular and Metabolic Research Unit, Laurentian University, Sudbury, ON, Canada, P3E 2C6.
Changqing XuDepartment of Pathophysiology, Harbin Medical University, Harbin, 150086, China. xucq45@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since online publication of this article, the authors noticed that there was an error in Figs. 2 and 4. In Fig. 2c the samples were mislabelled, the correct labelling order is 'Control, HG, HG + NPS R568, HG + Calhex231'. In Fig. 4c, an incorrect image was used to compile the HG + NPS R568 group, meaning the control was accidentally duplicated. The corrected images are provided below. The authors confirm that these errors did not influence the reported data, discussion, or conclusion. The authors apologise for any inconvenience to readers arising from this error.

Identifiers

PMID32958752
PMCPMC7506004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.